TTD Forensic analysis
Detailed research
PART 1: TRADING EXECUTION
1. Trading Setup & Entry Strategy
- >Entry Zone: $20.15 - $20.60. We are currently testing the lower Bollinger Band ($20.14). Do not chase strength; look for a stabilization or a "long wick" candle on the daily chart within this support shelf.
- >Stop Loss: $19.85 (Hard Stop). Any breach below the lower Bollinger Band with volume confirms a move into lower-low territory, invalidating the current support thesis.
- >Scaling Strategy: Enter 40% of target position at $20.50. Add 30% at $20.20 if tested. Final 30% on a confirmed breakout above $21.50 (reclaiming the 5-day SMA).
- >Take Profit: $22.95 (50-day SMA) as T1, $24.50 as T2.
- >Risk/Reward: ~1:2.8.
2. Executive Summary
TTD is currently in a BEARISH_DOWNTREND, hovering at $21.16 after a 12% Q1 revenue growth print that failed to excite the market. While fundamentally strong with high cash reserves, the combination of ongoing securities litigation and technical weakness suggests a cautious approach. Rating: HOLD / SPECULATIVE BUY ON OVERSOLD.
PART 2: DETAILED RESEARCH
3. Recent Material Events (8-K Analysis)
Recent filings (May 2026) indicate ongoing administrative updates and potential internal management shifts, likely following the CSO exit mentioned in market news. No material debt covenant breaches; the new $750M Revolving Facility (April 2026) provides liquidity, though the market is ignoring this in favor of growth concerns.
4. Insider Trading Activity
Recent Form 4 filings (May 19, 2026) show high-frequency activity, typical of planned RSU vestings or 10b5-1 sell programs. No significant open-market buying from the C-suite is noted, which would have provided a much-needed confidence floor.
5. Financial Health & Forensics
- >Cash Position: Strong ($878M cash + $528M short-term investments).
- >Revenue Quality: Net revenue growth of 12% YoY is decelerating compared to historical performance.
- >Profitability: GAAP Net Income fell 21% YoY, impacted by higher platform operating expenses (hosting costs +27%).
- [WARN]** Forensic Flag**: SBC remains high ($109M in Q1), and the reliance on stock repurchases ($174M in Q1) to mask dilution is a standard but aggressive capital allocation strategy.
6. Technical Analysis & Trade Timing
- >Trend: BEARISH_DOWNTREND. Price is significantly below the 50-day ($22.98) and 200-day ($37.87) SMAs.
- >RSI: 42.63 (Neutral). Not yet oversold, implying room for further downside if macro sentiment shifts.
- >Reconciliation: While the stock is "cheaper" than it has been, the Death Cross structure remains firmly in place. This is a "falling knife" scenario. Value Trap warning is active; only enter on technical confirmation of a bottoming pattern (e.g., RSI divergence or high-volume reversal).
7. Investment Recommendation
HOLD. The fundamental long-term story remains, but the technicals suggest no reason to rush. The stock is in a multi-month downtrend. Wait for the $20.00 floor to hold for at least 3-5 sessions before deploying capital.